TY  - JOUR

T1  - Addition of dendritic cell vaccination to conditioning cyclophosphamide and chemoembolisation in patients with hepatocellular carcinoma: the ImmunoTACE trial.

JO  - Clinical Cancer Research

UR  - https://doi.org/10.1158/1078-0432.ccr-25-0142

PY  - 2025/06/11

AU  - Ma YT

AU  - Zuo J

AU  - Kirkham A

AU  - Curbishley S

AU  - Blahova M

AU  - Rowe AL

AU  - Bathurst C

AU  - Mehrzad H

AU  - Karkhanis S

AU  - Punia P

AU  - James MW et al

ED  - 

DO  - DOI: 10.1158/1078-0432.ccr-25-0142

PB  - American Association for Cancer Research (AACR)

Y2  - 2025/06/24

ER  -